Connect with a Global Community of NK Experts
The NK field has endured a challenging investment climate, yet recent clinical readouts, regulatory designations, and renewed activity across oncology and autoimmunity signal a crucial turning point for this determined community.
As the only industry meeting dedicated solely to NK cell therapies, engagers, bispecifics, and cytokine-based approaches, the 11th Innate Killer Summit remains the trusted home of the NK field, uniting the entire active landscape under one roof for focused discussion, scientific depth, and high-value partnering.
With a redesigned single-track agenda that elevates interaction quality and fosters a true community atmosphere, and with leading researchers and pioneering NK biotechs, sponsors gain unrivalled access to the senior scientific and commercial decision makers still advancing NK pipelines despite market consolidation.
This is a rare opportunity for solution providers to strengthen their visibility, influence future partnerships, and position themselves as essential collaborators at a moment when momentum is returning and the next wave of NK innovation is taking shape.
A Pivotal Year for NK Therapies
ImmunityBio has delivered encouraging signals with chemotherapy free CD19 CAR NK showing complete responses in lymphoma patients, with one case demonstrating a 15-month complete response.
Senti Bio has received FDA orphan drug designation for SENTI 202, its logic gated off the shelf CAR NK therapy.
GC Cell has dosed its first patient in a phase 1 trial for a CD5 CAR NK therapy for T cell lymphoma.
NKGen has expanded into neurodegenerative indications, including programmes in Alzheimer’s disease, and continues to progress its NK partnerships internationally.
For solution providers, these advances show that the sector is far from retreating. Developers are actively refining gene-engineering strategies, trial designs, IL-15-based durability enhancements, combination approaches, and scalable manufacturing. They are also expanding into autoimmune indications where the safety profile of NK cells holds significant promise.
Your partnership at the 11th Innate Killer Summit positions you at the centre of this renewed activity.
Why Become a Partner in 2026?
Strengthen Your Visibility Alongside the Investment Cycle Rebounds
NK companies are preparing for their next phase of growth, and many are generating new data designed to re-attract investment. Solution providers have a unique opportunity to build relationships at a time when developers are reassessing their outsourcing strategies and planning for future scalability.
Distinguish Yourself from the Crowd
In the NK market, showcasing reliability in evolving times is essential. This summit allows you to differentiate your company by showcasing your innovations, expertise, and unique value propositions. With fewer direct competitors in this niche field, your brand can shine as a clear leader in advancing next generation immunotherapies.
Engage the Companies That Are Still Advancing NK Pipelines
The current NK landscape is smaller, but the companies that remain are deeply committed to advancing their programs. This summit brings them together for high-quality discussions on persistence, durability, process optimization, biomarkers, clinical trial design, and genetic engineering. These are the companies actively buying, partnering, and building new vendor relationships.
Uncover the Next Market Trend
With cutting-edge scientific sessions, pipeline insights, and emerging technology showcases, the summit is a hub for forward-looking intelligence. With 8+ sessions of new clinical data, plus sessions on AI and new innovations, discover the new needs of the NK Field.
Influence Senior Decision Makers
The summit brings together leading researchers, biotech executives, and academic innovators working at the forefront of NK cell therapy. Partnering gives you exclusive access to these thought leaders, creating opportunities to exchange ideas, validate product fit, gather expert feedback, and forge influential relationships.
Show Your Commitment to a Resilient and Passionate Field
The NK community values solution providers who stand by the sector through both consolidation and resurgence. Sponsoring now demonstrates confidence in the field and strengthens your long-term positioning as a trusted partner.
Key Services & Solutions
11th Innate Killer Summit attendees from leading biopharma organizations and academia are actively seeking innovative service and solution providers with expertise in the following areas:
CDMO
NK developers need CDMO support to optimize processes from early development through to late-stage readiness.
At this summit, CDMOs can:
- Meet biotech startups and clinical-stage companies seeking scalable, GMP-compliant manufacturing partners
- Showcase your capabilities in viral vector production, cell expansion, and fill-finish services
- Position your brand as a trusted partner in accelerating NK cell therapy pipelines from bench to bedside
Apheresis & Cell Sorting Medical Device
As NK developers move towards standardised off the shelf products, reliable collection and high quality starting material remain essential.
Partners can:
- Demonstrate your cutting-edge platforms for leukapheresis, cell enrichment, and closed-system processing
- Engage with clinical trial designers and translational researchers seeking reliable, high-yield cell collection technologies
- Highlight your role in improving patient access and product consistency
Gene Engineering & Editing Technologies
Complex NK engineering is rapidly expanding across CAR NK, engager NK, and cytokine-armed NK.
You can:
- Present your CRISPR, TALEN, or viral/non-viral gene delivery tools to a targeted audience of NK cell engineers
- Explore collaborations with academic labs and biotech firms pushing the boundaries of immune cell reprogramming
- Position your platform as essential to the next wave of off-the-shelf and allogeneic therapies
Raw Materials & Reagents
As NK companies refine gene engineering, formulation, cytokine supplementation and expansion protocols, they require high quality, reliable inputs.
You can:
- Promote your GMP-grade cytokines, media, and reagents critical for NK cell expansion and activation
- Build relationships with process development teams optimizing culture conditions and assay performance
- Gain visibility as a quality-driven supplier in a highly regulated space
Analytical & Assay Technologies
Precise characterization and potency assessment remain major bottlenecks in NK development.
Partners can:
- Showcase your flow cytometry, potency assays, and QC platforms tailored for innate immune cell characterization
- Help developers meet regulatory expectations for identity, purity, and functional testing
- Position your tools as essential for IND-enabling studies and clinical monitoring
Whether you provide manufacturing expertise, analytical precision, engineering capabilities, or critical materials, the 11th Innate Killer Summit offers an intimate, highly engaged, and strategically important audience.
By sponsoring this year, you place your organization at the forefront of a field that is rebuilding confidence through new clinical signals, expanding indications, and renewed scientific momentum. You also demonstrate your commitment to the long-term success of NK therapies and the patients who stand to benefit.
All the sponsorship options are entirely customizable to suit your needs and budget. Get in touch to discuss this in more detail.
Hear What Our Past Sponsors Have to Say
I found the speakers are more open to discuss and presenting their data in comparison to other meetings. To grow the NK cell therapy field and market, it takes a village, and I feel that various groups are interested in collaborations.
Director of Product Management & Marketing, Agilent
Great speakers and topics were relevant.
G-Rex Optimization Specialist, ScaleReady
Highly knowledgeable presenters. Good willingness of attendees in sharing knowledge and experiences (including unpublished data).
Senior Scientist, FujiFilm
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as lanyards, exclusive dinners and tours to help elevate your brand.
Presenting Slots
Data-driven or case study-led presentations to position yourself as a thought-leader.
Leading Innovation
Expert panels to shape forward-thinking discussions.
Full Delegate List
Gain exclusive access to the Full Delegate List to plan your conversations in advance.
Exhibit
Raise brand awareness and answer questions from prospect customers.
Network
Engage in 1-2-1 conversations with industry or be part of the organized networking options to generate commercial collaborations.
Innovative Networking
Host breakfast, lunches, dinners for drinks receptions to have exclusive time with your target audience.
Champion the Industry
Be part of the Cell Therapy community community and position yourself as an advocate for innovation and achievements in the Innate Killler space.
Branding
On-site and website branding to highlight your company at the forefront of the Innate Killer field.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Jake Bennett
Partnerships Director
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.